Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Karolinska Development Shareholders Equity (Quarterly): 117.06M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 117.06M |
December 31, 2023 | 123.85M |
September 30, 2023 | 114.40M |
June 30, 2023 | 113.88M |
March 31, 2023 | 117.20M |
December 31, 2022 | 119.11M |
September 30, 2022 | 110.57M |
June 30, 2022 | 125.08M |
March 31, 2022 | 140.80M |
December 31, 2021 | 107.34M |
September 30, 2021 | 112.65M |
June 30, 2021 | 116.44M |
March 31, 2021 | 88.94M |
December 31, 2020 | 97.73M |
September 30, 2020 | 79.68M |
June 30, 2020 | 94.79M |
March 31, 2020 | 87.93M |
December 31, 2019 | 107.84M |
September 30, 2019 | 27.62M |
June 30, 2019 | 30.74M |
March 31, 2019 | 29.85M |
December 31, 2018 | 32.96M |
September 30, 2018 | 31.64M |
June 30, 2018 | 30.68M |
March 31, 2018 | 29.67M |
Date | Value |
---|---|
December 31, 2017 | 32.66M |
September 30, 2017 | 28.97M |
June 30, 2017 | 4.870M |
March 31, 2017 | 7.031M |
December 31, 2016 | 3.289M |
September 30, 2016 | 6.166M |
June 30, 2016 | 8.362M |
March 31, 2016 | 18.23M |
December 31, 2015 | 29.48M |
September 30, 2015 | 44.13M |
June 30, 2015 | 48.22M |
March 31, 2015 | 164.91M |
December 31, 2014 | 162.12M |
September 30, 2014 | 224.26M |
June 30, 2014 | 259.90M |
March 31, 2014 | 298.54M |
December 31, 2013 | 244.04M |
September 30, 2013 | 307.06M |
June 30, 2013 | 307.02M |
March 31, 2013 | 316.90M |
December 31, 2012 | 325.39M |
September 30, 2012 | 244.39M |
June 30, 2012 | 243.56M |
March 31, 2012 | 271.31M |
December 31, 2011 | 272.67M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
27.62M
Minimum
Sep 2019
140.80M
Maximum
Mar 2022
101.68M
Average
111.61M
Median
Shareholders Equity (Quarterly) Benchmarks
Abliva AB | 7.025M |
Calliditas Therapeutics AB | 33.26M |
Oncopeptides AB | 12.22M |
Olink Holding AB | 502.70M |
BioInvent International AB | 115.71M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 118.29M |
Total Liabilities (Quarterly) | 1.233M |
Current Ratio | 6.162 |